The FY22 Work Plan for the period October 1, 2021 - September 30, 2022 covers the fourth year of the five-year program. The fourth-year work plan continues to build on the previous achievements of the program and consider lessons learned. It aims to achieve the following three intermediate results (IRs):
IR1: Increased mass drug administration (MDA) coverage among at-risk populations in endemic countries
IR2: Strengthened country environment for implementation and management of national NTD programs (NTDPs)
IR3: Sustained MDA coverage among at-risk populations in endemic countries
TypeWork PlanYear of publication
DiseaseAll Preventive Chemotherapy NTDs, Lymphatic Filariasis, Onchocerciasis, Schistosomiasis, Soil-Transmitted Helminthiasis, TrachomaCountryAll Countries, Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone, TogoFocus AreasMass Drug Administration (MDA), MDA implementation, Community outreach, Drug procurement & supply chain support, Cross-border initiatives, Annual training for MDA, Support for NTD Sustainability, Advocacy and policies, Cross-sector collaboration, NTD governance, Strategic health information, NTD Capacity Building, Monitoring, Evaluation, Research, Learning and Adapting (MERLA), Disease-specific assessments, post-treatment surveillance, and related training, Disease & morbidity mapping & assessment, Learning & quality improvement, Data for decision-making, Operational research, Dossier developmentPartnersAIM Initiative, Deloitte, FHI360, HDI, HKI, World Vision
Sign up to receive updates
Wanting to know more about Act to End NTDs | West?